HIV診断市場：現状分析と予測（2022年～2028年）

世界のHIV診断の市場規模は、予測期間中に約9％の大幅な成長率で成長すると予測されています。世界のHIV診断市場は、世界的なHIVの有病率上昇、献血数の増加、および政府や規制機関による取り組みの増加により、上昇すると予想されています。さらに、急速な技術進歩と、新規かつ高度な診断検査の開発および市場投入に注力する主要な業界企業の増加も、世界のHIV診断市場を牽引しています。

当レポートでは、世界のHIV診断市場について調査し、COVID-19の影響、セグメント別の市場洞察、市場機会や動向、主要企業のプロフィールなどの情報を提供しています。

目次

第1章 市場イントロダクション

第2章 調査手法/前提条件

第3章 市場要約

第4章 エグゼクティブサマリー

第5章 COVID-19のHIV診断市場への影響

第6章 HIV診断市場収益（2020年～2028年）

第7章 市場洞察：検査タイプ別

• 抗体検査
• ウイルス負荷検査
• CD4検査
• その他

第8章 市場洞察：エンドユーザー別

• 診断研究所
• 病院
• その他

第9章 市場洞察：地域別

• 北米
  • 米国
  • カナダ
  • その他
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他
• その他の地域

第10章 HIV診断市場力学

• 市場促進要因
• 市場の課題
• 影響分析

第11章 HIV診断の市場機会

第12章 HIV診断の市場動向

第13章 需要側と供給側の分析

• 需要側分析
• 供給側分析

第14章 バリューチェーン分析

第15章 競合シナリオ

• 競合情勢
  • ポーターのファイブフォース分析

第16章 企業プロファイル

• Siemens Healthineers
• F. Hoffmann-La Roche Ltd
• Abbott Laboratories
• Danaher Corporation
• Becton, Dickinson & Company
• Bio-Rad Laboratories
• Thermo-Fisher Scientific Inc.
• Merck KGaA
• Hologic, Inc.
• OraSure Technologies

第17章 免責事項

Global HIV Diagnostics Market is expected to grow at a significant rate of around 9% during the forecast period. The global HIV Diagnostics market is anticipated to witness an uptick owing to the growing prevalence of HIV globally, rising number of blood donations, and increasing initiatives by government and regulatory bodies. For instance, the Egyptian government declared in 2020 that all 27 governorates in the nation would have access to free, confidential HIV diagnostic testing. Furthermore, the rapid technological advancement coupled with the growing focus of key industry players to develop and launch novel & advanced diagnostic tests in the market is also driving the HIV diagnostics market across the globe. For example, in 2020, Elecsys HIV Duo immunoassay was introduced in the United States by F. Hoffmann-La Roche AG following approval from the U.S. Food and Drug Administration (U.S. FDA) in April 2020. this is the first 4th generation HIV testing option in the United States that enables distinct detection of HIV p24 antigen and anti-HIV antibodies.

Siemens Healthineers, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Danaher Corporation, Becton, Dickinson & Company, Bio-Rad Laboratories, Thermo-Fisher Scientific Inc., Merck KGaA, Hologic, Inc., OraSure Technologies are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst test type, viral load test category to witness higher CAGR during the forecast period"

Based on the test type, the HIV diagnostics market is segmented into antibody tests, viral load tests, CD4 tests, and others. The viral load test segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe owing to the increasing frequency of viral load testing in ART-treated HIV patients. Also, these tests improve the efficacy of treatment and produce better results in infected individuals which in turn is also contributing to the increased demand for this test.

"Amongst end-user, the diagnostic laboratories to hold a significant share in the market in 2020"

Based on end-user, the market is fragmented into diagnostic laboratories, hospitals, and others. The diagnostic laboratories segment is expected to grab a considerable market share in 2020 and is expected to grow with a lucrative CAGR during the forecast period owing to the growing awareness of HIV/AIDS among the population globally. Also, rising investments, growing advancement in technology and the presence of advanced diagnostics tools in these laboratories are also some of the factors driving the market of this segment.

"North America to hold a significant share in the market"

For a better understanding of the market adoption of the HIV Diagnostics industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. The major factors such as well-established healthcare infrastructure and the rising incidences of HIV owing to the lack of preventive techniques adopted by people in the region. For instance, In 2019, the estimated number of HIV infections in the U.S. was 34,800 and the rate was 12.6 (per 100,000 people). Furthermore, an increase in government initiatives and an increasing awareness among the population are also driving the market.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The global HIV diagnostics market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the HIV Diagnostics Market
• 2.2. Research Methodology of the HIV Diagnostics Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE HIV DIAGNOSTICS MARKET

6 HIV DIAGNOSTICS MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY TEST TYPE

• 7.1. Antibody Tests
• 7.2. Viral Load Tests
• 7.3. CD4 Tests
• 7.4. Others

8 MARKET INSIGHTS BY END-USER

• 8.1. Diagnostic Laboratories
• 8.2. Hospitals
• 8.3. Others

9 MARKET INSIGHTS BY REGION

• 9.1. North America
  • 9.1.1. U.S.
  • 9.1.2. Canada
  • 9.1.3. Rest of North America
• 9.2. Europe
  • 9.2.1. Germany
  • 9.2.2. U.K.
  • 9.2.3. France
  • 9.2.4. Italy
  • 9.2.5. Spain
  • 9.2.6. Rest of Europe
• 9.3. Asia-Pacific
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. India
  • 9.3.4. Rest of Asia-Pacific
• 9.4. Rest of World

10 HIV DIAGNOSTICS MARKET DYNAMICS

• 10.1. Market Drivers
• 10.2. Market Challenges
• 10.3. Impact Analysis

11 HIV DIAGNOSTICS MARKET OPPORTUNITIES

12 HIV DIAGNOSTICS MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

• 13.1. Demand Side Analysis
• 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 COMPETITIVE SCENARIO

• 15.1. Competitive Landscape
  • 15.1.1. Porters Fiver Forces Analysis

16 COMPANY PROFILED

• 16.1. Siemens Healthineers
• 16.2. F. Hoffmann-La Roche Ltd
• 16.3. Abbott Laboratories
• 16.4. Danaher Corporation
• 16.5. Becton, Dickinson & Company
• 16.6. Bio-Rad Laboratories
• 16.7. Thermo-Fisher Scientific Inc.
• 16.8. Merck KGaA
• 16.9. Hologic, Inc.
• 16.10. OraSure Technologies

17 DISCLAIMER